APPROVAL OF THE NOVAVAX COVID 19 VACCINE
Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.
![Headshot of a woman](https://metroplus.org/wp-content/uploads/2022/09/morshedf_MPH_Web_Headshot_8-30-scaled-150x150-c-default.jpg)
![Headshot of a woman](https://metroplus.org/wp-content/uploads/2022/09/liulu_MPH_Web_Headshot_8-29-scaled-150x150-c-default.jpg)
![Headshot of a man](https://metroplus.org/wp-content/uploads/2022/09/santic_MPH_Web_Headshot_8-30-150x150-c-default.jpg)
![Headshot of a man](https://metroplus.org/wp-content/uploads/2022/09/marshgu_MPH_Web_Headshot_8-29-scaled-150x150-c-default.jpg)
![Headshot of a woman](https://metroplus.org/wp-content/uploads/2022/09/lugocl-_MPH_Web_Headshot_8-29-scaled-150x150-c-default.jpg)
Speak To Someone In Your Community
Find someone in your neighborhood and in your language